Mach 1 Financial Group, LLC Merck & Co., Inc. Transaction History

Mach 1 Financial Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $627,627 - $683,010	6,265 Added 60.59%	16,605 $1.81 Million
Q3 2023 Oct 17, 2023	SELL	$102.95 - $114.33 $1.43 Million - $1.59 Million	-13,882 Reduced 57.31%	10,340 $1.06 Million
Q2 2023 Jul 28, 2023	BUY	$108.61 - $118.38 $2.59 Million - $2.82 Million	23,813 Added 5822.25%	24,222 $2.79 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $966,091 - $1.08 Million	-9,385 Reduced 95.82%	409 $43,000
Q4 2022 Feb 02, 2023	BUY	$87.44 - $112.11 $825,083 - $1.06 Million	9,436 Added 2635.75%	9,794 $1.09 Million
Q3 2022 Nov 08, 2022	SELL	$84.53 - $94.96 $10,143 - $11,395	-120 Reduced 25.1%	358 $30,000
Q2 2022 Aug 04, 2022	BUY	$83.49 - $94.64 $15,863 - $17,981	190 Added 65.97%	478 $43,000
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $3,528 - $3,955	-48 Reduced 14.29%	288 $23,000
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $24,286 - $30,421	336 New	336 $25,000
Q3 2021 Oct 18, 2021	SELL	$71.68 - $78.83 $23,439 - $25,777	-327 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $22,517 - $26,522	327 New	327 $25,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Mach 1 Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Mach 1 Financial Group, LLC with notifications on news.